Question 1

What are the potential side effects of R-3750?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if I experience worsening symptoms?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

Question 6

What are the logistics of attending visits at the study locations?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the R-3750 in Patients With Mild to Moderate Ulcerative Colitis clinical trial (NCT05666960). Contact the study team or your healthcare provider for specific answers.

What this study is about